CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on June 25, 2009
Clin J Am Soc Nephrol 4: 1508-1514, 2009
© 2009 American Society of Nephrology
doi: 10.2215/CJN.02160309

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.02160309v1
4/9/1508    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Johal, M.
Right arrow Articles by Levin, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johal, M.
Right arrow Articles by Levin, A.

Moving Points in Nephrology

Vitamin D and Parathyroid Hormone in General Populations: Understandings in 2009 and Applications to Chronic Kidney Disease

Manraj Johal, and Adeera Levin

Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada

Correspondence: Dr. Adeera Levin, Department of Medicine, Division of Nephrology, University of British Columbia, St. Paul's Hospital, 1081 Burrard, Room 60101A, Vancouver BC, Canada V6Z 1Y8. Phone: 604-682-2344, ext. 62232; Fax: 604-806-8120; E-mail: alevin{at}providencehealth.bc.ca

Vitamin D is now recognized as an important prohormone in health and disease. Its role in immunoregulation and cardiovascular and bone health has become topical in the lay press and the medical press in the past 5 yr. The target audience for this review includes the interested clinician and researchers. The prevalence of chronic kidney disease in the general population has further increased the interest and perhaps the applicability of findings of population studies. The basic physiology of vitamin D and receptor activation and biologic importance is reviewed, as well as various vitamin D analogues and nomenclature. Issues related to measurement of vitamin D and parathyroid hormone have the potential to complicate the clinical use of these tests and should be understood by all clinicians so as to ensure informed decision making and stimulate interest in participation in clinical trials. The epidemiology of vitamin D deficiency and supplementation in association with health status and disease status is reviewed, and issues related to association versus causation are highlighted. Some recommendations for pragmatic approaches and study design are suggested.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society of Nephrology.